18 January 2022 – InSilicoTrials – Modeling and simulation in drug development, a leader in simulation software solutions for healthcare, announced today his appointment. Torchia gained 15 years of experience in the tech industry, working in multinational companies such as Dassault Systèmes and Siemens.
Most recently he led the Sales Strategy as Delmia Geo Leader for South Europe at Dassault Systèmes, actively supporting customers in their business transformation journey.
Previously, he spent 4 years in Sao Paulo, managing the Brazilian branch of Hyla Soft, a global IT company that provides technology solutions to improve productivity and efficiency within Manufacturing Engineering, Manufacturing Operations, and Sales and Operations Planning processes.
With a degree in Computer Engineering, married with two daughters, Mario is passionate about technology, innovation, arts, and water sports. At InSilicoTrials he will lead the Sales & Marketing team, leveraging his impressive experience at big and medium-sized companies, his strategic market vision, and his abilities to help startups grow on international markets.
“We are very pleased to welcome Mario to our team”, says Luca Emili, CEO, and Founder of InSilicoTrials. “As a successful and experienced sales executive, he brings a unique mix of global market understanding and proven revenue generation capabilities to InSilicoTrials. The fact that he believes in our vision and our efforts to improve the lives of millions of patients worldwide through cutting-edge technology will be advantageous to our company that is rapidly growing on international markets”.
About InSilicoTrials Technologies
InSilicoTrials is a European life sciences company founded in 2018 by a team of healthcare, cybersecurity, and digital innovation experts, which aims to revolutionize the industry thanks to an innovative digital simulation platform. Today, the very long and expensive development, as well as the subsequent registration/certification processes for new drugs and medical devices, are becoming unsustainable, especially for SMEs. Modeling and simulation can reduce these costs up to 50% and greatly accelerate the go-to-market of new products, allowing companies to exploit patents for a longer period. Regulatory agencies are recommending companies to adopt these practices, but many of these lacks the high expertise, expensive software, and IT infrastructure, needed to develop and use models. InSilicoTrials solves these problems by selecting and collecting the best models from top researchers around the world and by integrating them with the solvers in a scalable IT platform, which makes it easier to use validated models without specific computational knowledge, paying only for the used resources. InSilicoTrials is currently working on five projects funded by the European Union: In Silico World, SimCardioTest, Brainteaser, TranSys, and Disc4All.